Peanut for peanut hypersensitivity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 3 registered trials.

Why this status

  1. 30 Jul 2014: Trial registered, NCT02203799
  2. 31 Jul 2014: Trial started, NCT02203799
  3. 16 Aug 2017: Trial registered, NCT03251508
  4. 3 Jan 2018: Trial started, NCT03251508

The trials

NCT01814241: Mechanisms of Desensitization During Peanut Oral Immunotherapy

State
Completed
Phase
Phase 2
People
20 taking part
Started
Apr 2013
Primary completion
Dec 2015
Arms
Open label peanut OIT
Results
Posted on the registry
  1. 19 Mar 2013: Trial registered
  2. 13 Mar 2017: Trial results posted

NCT02203799: Peanut Oral Immunotherapy in Children With Peanut Allergy (Peanut Flour)

State
Completed
Phase
Phase 1
People
15 taking part
Started
31 Jul 2014
Primary completion
11 Feb 2020
Arms
Peanut Oral Immunotherapy (POIT)
Results
Posted on the registry
  1. 30 Jul 2014: Trial registered
  2. 31 Jul 2014: Trial started
  3. 11 Feb 2020: Trial completed
  4. 19 Jan 2024: Trial results posted

NCT03251508: Salvage Peanut Oral Immunotherapy Study

State
Completed
Phase
Phase 1 and Phase 2
People
15 taking part
Started
3 Jan 2018
Primary completion
23 Nov 2021
Arms
Peanut OIT/dietary peanut
Results
Posted on the registry
  1. 16 Aug 2017: Trial registered
  2. 3 Jan 2018: Trial started
  3. 23 Nov 2021: Trial completed
  4. 30 Jan 2023: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Also known as Open label peanut OIT, Peanut OIT, Peanut Oral Immunotherapy (POIT), Peanut Oral Immunotherapy - Peanut Flour.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.